mRNA-4157 (V940) is a personalized tumor mRNA vaccine. By utilizing lipid nanoencapsulation technology, mRNA-4157 can deliver up to 34 tumor-specific antigens (also called tumor neoantigens) that are specifically tailored for tumor patients into theRead More…